Predicting psychosis based on clinical, neurocognitive, and linguistic factors
DOI:
https://doi.org/10.20453/rnp.v88i1.6251Keywords:
psychotic disorder, precision medicine, clinical relevance, neurobehavioral cognitive status examination, linguisticsAbstract
Predicting the onset of psychosis is crucial for early intervention and improved outcomes. This review examines the current state of prediction models based on clinical, neurocognitive, and linguistic factors. Clinical predictors, including sociodemographic characteristics, family history, and subthreshold psychotic symptoms, have shown promise in identifying people at risk, and some models achieve concordance indices of 0.79-0.80 in external validation. Neurocognitive evaluation, particularly of verbal learning, processing speed, and attention/vigilance, has emerged as a cost-effective predictor, although the effect sizes remain modest. Recent advances in natural language processing have enabled automated analysis of speech patterns, with reduced semantic coherence and specific linguistic features predicting the transition to psychosis with precisions of up to 83%. Although these approaches show promise individually, the integration of multiple predictors may maximize predictive accuracy. Current limitations include small sample sizes in many studies, especially for linguistic analyses, and the need for broader population-level applicability beyond clinical high-risk groups. Dynamic prediction models that account for temporal changes in risk factors show improved performance over static approaches. More research is needed, particularly external validation studies in diverse populations, to develop comprehensive preventive strategies that can be implemented at the primary level. The field continues to evolve with emerging variables and advanced analytical methods, working toward an individualized application of prediction tools.
Downloads
References
Lieberman JA, First MB. Psychotic disorders. N Engl J Med [Internet]. 2018; 379(3): 270-280. Available from: https://doi.org/10.1056/nejmra1801490
Clauss JA, Foo CY, Leonard CJ, Dokholyan KN, Cather C, Holt DJ. Screening for psychotic experiences and psychotic disorders in general psychiatric settings: a systematic review and meta-analysis. medRxiv [preprint on the Internet]. 2024. Available from: https://doi.org/10.1101/2024.04.14.24305796
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry [Internet]. 2022; 9(2): 137-150. Available from: https://doi.org/10.1016/s2215-0366(21)00395-3
Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, et al. Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophr Res [Internet]. 2018; 194: 4-12. Available from: https://doi.org/10.1016/j.schres.2017.06.039
Álvarez A, Guàrdia A, González-Rodríguez A, Betriu M, Palao D, Monreal JA, et al. A systematic review and meta-analysis of suicidality in psychotic disorders: Stratified analyses by psychotic subtypes, clinical setting and geographical region. Neurosci Biobehav Rev [Internet]. 2022; 143: 104964. Available from: https://doi.org/10.1016/j.neubiorev.2022.104964
Aguey-Zinsou M, Scanlan JN, Cusick A. A scoping and systematic review of employment processes and outcomes for young adults experiencing psychosis. Community Ment Health J [Internet]. 2023; 59(4): 728-755. Available from: https://doi.org/10.1007/s10597-022-01056-z
Takizawa N, Melle I, Barrett EA, Nerhus M, Ottesen AA. The influence of mental health literacy, migration, and education on the duration of untreated psychosis. Front Public Health [Internet]. 2021; 9: 705397. Available from: https://doi.org/10.3389/fpubh.2021.705397
Fusar-Poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, et al. Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiatry [Internet]. 2017; 74(5): 493-500. Available from: https://doi.org/10.1001/jamapsychiatry.2017.0284
Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg EW. The science of prognosis in psychiatry. JAMA Psychiatry [Internet]. 2018; 75(12): 1289-1297. Available from: https://doi.org/10.1001/jamapsychiatry.2018.2530
Fernandes BS, Williams LM, Steiner J, Leboyer M, Carvalho AF, Berk M. The new field of ‘precision psychiatry’. BMC Med [Internet]. 2017; 15: 80. Available from: https://doi.org/10.1186/s12916-017-0849-x
Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, et al. The psychosis high-risk state. JAMA Psychiatry [Internet]. 2013; 70(1): 107-120. Available from: https://doi.org/10.1001/jamapsychiatry.2013.269
Salazar de Pablo G, Radua J, Pereira J, Bonoldi I, Arienti V, Besana F, et al. Probability of transition to psychosis in individuals at clinical high risk. JAMA Psychiatry [Internet]. 2021; 78(9): 970-978. Available from: https://doi.org/10.1001/jamapsychiatry.2021.0830
Montemagni C, Bellino S, Bracale N, Bozzatello P, Rocca P. Models predicting psychosis in patients with high clinical risk: a systematic review. Front Psychiatry [Internet]. 2020; 11: 223. Available from: https://doi.org/10.3389/fpsyt.2020.00223
Worthington MA, Cao H, Cannon TD. Discovery and validation of prediction algorithms for psychosis in youths at clinical high risk. Biol Psychiatry Cogn Neurosci Neuroimaging [Internet]. 2020; 5(8): 738-747. Available from: https://doi.org/10.1016/j.bpsc.2019.10.006
Mirzakhanian H, Singh F, Cadenhead KS. Biomarkers in psychosis: an approach to early identification and individualized treatment. Biomark Med [Internet]. 2014; 8(1): 51-57. Available from: https://doi.org/10.2217/bmm.13.134
Sanfelici R, Dwyer DB, Antonucci LA, Koutsouleris N. Individualized diagnostic and prognostic models for patients with psychosis risk syndromes: a meta-analytic view on the state of the art. Biol Psychiatry [Internet]. 2020; 88(4): 349-360. Available from: https://doi.org/10.1016/j.biopsych.2020.02.009
Longato E, Vettoretti M, Di Camillo B. A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models. J Biomed Inform [Internet]. 2020; 108: 103496. Available from: https://doi.org/10.1016/j.jbi.2020.103496
Hartman N, Kim S, He K, Kalbfleisch JD. Pitfalls of the concordance index for survival outcomes. Stat Med [Internet]. 2023; 42(13): 2179-2190. Available from: https://doi.org/10.1002/sim.9717
Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart [Internet]. 2012; 98(9): 683-690. Available from: https://doi.org/10.1136/heartjnl-2011-301246
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Joshep Revilla Zúñiga, Lesly Vargas Balvin, José Revilla Urquizo

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.















RNP is distributed under a